Shareholders Equity: The sum of preferred and common equity items.
WAVE Life Sciences Ltd. (WVE) had Shareholders Equity of $124.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$7.61M |
|
$-53.85M |
|
-- |
|
$7.61M |
|
$63.96M |
|
$-56.35M |
|
$2.50M |
|
$-53.85M |
|
$-53.85M |
|
$-53.85M |
|
$-53.85M |
|
$-53.85M |
|
$-53.85M |
|
$-56.35M |
|
$-54.12M |
|
167.74M |
|
167.74M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$215.49M |
|
$8.20M |
|
$25.89M |
|
$241.38M |
|
$85.90M |
|
-- |
|
$30.93M |
|
$116.83M |
|
$124.55M |
|
$124.55M |
|
|
Shareholders Equity |
$124.55M |
160.29M |
|
| Cash Flow Statement Financials | |
$-153.72M |
|
$-0.72M |
|
$48.54M |
|
$305.84M |
|
$200.01M |
|
$-105.82M |
|
$17.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-740.71% |
|
-740.71% |
|
-- |
|
-707.83% |
|
-707.83% |
|
$-154.44M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.76 |
|
118.30 |
|
-43.24% |
|
-43.24% |
|
-22.31% |
|
-43.24% |
|
$0.78 |
|
$-0.92 |
|
$-0.92 |
|